QdataⓇ Parkinson’s Disease Insights Only Found Here
Qdata Parkinson’s Disease is a real-world data set that offers a detailed view into the Parkinson’s Disease patient journey, including signs and symptoms derived from patient notes from the Axon RegistryⓇ.
Get exclusive access to curated variables from EHR unstructured notes such as tremor, bradykinesia, rigidity, postural instability, motor complications of dopaminergic therapy and more.
Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes.
Qdata spans ophthalmology, neurology, and urology to help life sciences teams unlock quality insights across the entire drug and device development cycle.
Why Qdata Parkinson's Disease for Your Next RWE Project
Exclusive Insights into the Parkinson’s Disease Patient Population
Only found here from the Axon Registry® Registry
Granular Understanding of Signs & Symptoms from Patient Notes
Cardinal signs to inform disease progression
Unique View into Treatments and Outcomes
Including motor complications of dopaminergic therapy
By the Numbers
~15K+
Patients with Parkinson’s Disease
3+
Years of Follow Up Data
~1,000+
Providers
*Data as of April 2023. Data counts represented are subject to change. Data counts for research purposes are dependent on project scope, feasibility and integration status.
Key Variables in Qdata® Parkinson’s Disease
Tremor
Bradykinesia
Rigidity
Postural Instability
Motor Fluctuations
Dyskinesia
"This new Qdata module will open up the opportunity to follow de-identified patients with idiopathic Parkinson's Disease and understand the patient journey, including prodromal states,"
- Heather Moss, M.D., Ph.D., associate professor at Stanford University and medical consultant to Verana Health
Unstructured Data Enables Deeper Understanding
Verana Health applies physician-informed algorithms to notes-based EHR data at scale to help extract key information from free-form text. These include cardinal signs such as tremor, bradykinesia, rigidity, postural instability and motor complications of dopaminergic therapy such as motor fluctuations and dyskinesia. These key variables and clinical outcomes can then be analyzed across large populations in a reliable manner.
This can give providers, researchers, and life science companies unprecedented insights into the journey of patients with Parkinson’s Disease.
Take a minute to submit your contact information and one of our team members will reach out to you.
About Verana Health
Verana Health® is a digital health company elevating quality in real-world data. Verana Health manages the clinical data registries for leading medical societies, including the American Academy of Neurology. Using its clinician-informed VeraQ® population health data engine, Verana Health supports providers with quality reporting requirements for the merit-based incentive payment system (MIPS) as well as offers opportunities for clinical trial participation and academic research. Verana Health’s quality data and insights help drive progress in medicine to enhance the quality of care and quality of life for patients.
.png "unnamed (13)")
.png?width=75&height=75&name=unnamed%20(14).png "unnamed (14)"){kind=icon}
.png?width=72&height=72&name=unnamed%20(15).png "unnamed (15)"){kind=icon}
.png?width=75&height=75&name=unnamed%20(16).png "unnamed (16)"){kind=icon}
.png?width=100&height=100&name=unnamed%20(17).png "unnamed (17)"){kind=icon}
